# SAMBA: Sexuality And Management of Benign Prostatic Hyperplasia With Alfuzosin

> **NCT00486785** · PHASE4 · COMPLETED · sponsor: **Sanofi** · enrollment: 431 (actual)

## Conditions studied

- Prostatic Hyperplasia

## Interventions

- **DRUG:** Alfuzosin

## Key facts

- **NCT ID:** NCT00486785
- **Lead sponsor:** Sanofi
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2006-04
- **Primary completion:** 2007-10
- **Final completion:** 2008-03
- **Target enrollment:** 431 (ACTUAL)
- **Last updated:** 2009-09-30


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00486785

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00486785, "SAMBA: Sexuality And Management of Benign Prostatic Hyperplasia With Alfuzosin". Retrieved via AI Analytics 2026-07-06 from https://api.ai-analytics.org/clinical/NCT00486785. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*